Clik here to view.
Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter,...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
View ArticleClik here to view.
スタリクラ、EUが資金提供するREPO4EUプロジェクトの計算型ドラッグリポジショニング活動を主導するために170万ユーロの資金を獲得
ジュネーブ （ビジネスワイヤ） —...
View ArticleClik here to view.
一般社団法人日本レストルーム工業会：温水洗浄便座の日本国内累計出荷数が１億台を達成
東京 （ビジネスワイヤ） — 日本のトイレメーカーで組織する一般社団法人 日本レストルーム工業会（本部：日本国 愛知県名古屋市、会長：清田 徳明（TOTO株式会社 代表取締役 社長執行役員）、以下「当工業会」）では、業界の統計開始（1987年）以来、温水洗浄便座の日本国内累計出荷数が、2022年6月に１億台を達成したことを確認しましたのでお知らせいたします。...
View ArticleClik here to view.
The Japan Sanitary Equipment Industry Association: Warm Water Spray Seat...
TOKYO The Japan Sanitary Equipment Industry Association, which is composed of Japanese companies engaged in the manufacturing of toilets (Headquarters: Nagoya, Aichi, Japan. President: Noriaki...
View ArticleClik here to view.
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to...
SINGAPORE Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited (hereafter referred to as “Intas”) today announced that the two companies...
View ArticleClik here to view.
日本卫生设备行业协会：日本温水喷淋马桶座出货量达1亿套
东京 (美国商业资讯)–由从事马桶制造的日本公司组成的日本卫生设备行业协会（总部：日本爱知县名古屋市。会长：Noriaki Kiyota [TOTO Ltd.总裁兼代表董事]，以下简称“协会”）自豪地宣布，自行业开始跟踪统计（1987年）以来，截至2022年6月，温水喷淋马桶座出货量已达1亿套。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral...
LOS ANGELES & NEW TAIPEI CITY, Taiwan SyneuRx™ International (TPEX:6575), a global biotech company focused on the development of new classes of drugs for COVID-19 and multiple major central...
View ArticleClik here to view.
Shionogi Begins Phase 3 Study in Japan of Akili’s Digital Treatment in...
BOSTON Akili Interactive (“Akili”), a leading digital medicine company, today announced the start of a pivotal Phase 3 randomized, controlled study of SDT-001 (a version of AKL-T01 localized for...
View ArticleClik here to view.
硕迪生物进一步扩大融资规模，推进糖尿病和肥胖症临床项目，并宣布公司英文名更改为 Structure Therapeutics
旧金山和上海 (美国商业资讯)–硕迪生物技术有限公司（前身为ShouTi Inc.）今日宣布，在2021年10月完成的一亿美元B轮融资的基础上，获得了3300万美元的超额认购。另外，硕迪生物的GSBR-1290（用于治疗2型糖尿病和肥胖症）单剂量递增一期临床研究已完成受试者给药。 此次扩展融资包括新投资者Deep Track Capital和Piper Heartland Healthcare...
View ArticleClik here to view.
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity...
SAN FRANCISCO & SHANGHAI Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, extending...
View ArticleClik here to view.
InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2...
BEIJING InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in...
View ArticleClik here to view.
Adalvo Acquires Its First Branded Product, Onsolis®
MSIDA, Malta The global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty...
View ArticleClik here to view.
CCC and Chinese Medical Association Publishing House Partner to Provide...
DANVERS, Mass. CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, has contracted with the Chinese Medical Association Publishing House (CMAPH) to offer document...
View ArticleClik here to view.
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age...
BEIJING Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of...
View ArticleClik here to view.
Adalvo收购其首个品牌产品Onsolis®
马耳他姆西达 (美国商业资讯)–全球制药公司Adalvo今天宣布，该公司与一家声誉良好的美国专业制药公司达成交易，收购了其首个品牌产品Onsolis®。这家美国制药公司是该产品的原始拥有者。...
View ArticleClik here to view.
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
SEOUL, South Korea & CAMBRIDGE, Mass. LG Chem recently announced that the Company has submitted an IND application to the US FDA for its first independent global Phase 3 clinical trial of its...
View ArticleClik here to view.
アダルボが初のブランド製品オンソリスを取得
マルタ・ムサイダ （ビジネスワイヤ） — 世界的製薬企業のアダルボは本日、当社初のブランド製品であるオンソリスを、その最初の保有者で、米国を拠点とするスペシャルティ製薬会社として評判の高い企業との契約締結により取得したと発表しました。...
View ArticleClik here to view.
Tongji Hospital Begins Installation of Mevion Proton Therapy System
LITTLETON, Mass. Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the accelerator for the...
View ArticleClik here to view.
FDA Grants Extension of Shelf-life ＆ Expiration Date for GenBody COVID-19 Ag...
JURUPA VALLEY, Calif. GenBody America, LLC, the U.S. affiliate of GenBody, Inc., a South Korean manufacturer of rapid diagnostic tests and reagents for point-of-care applications for COVID-19, today...
View ArticleClik here to view.
World’s First Discovery of Scallop-derived Plasmalogens Enhancing Antiviral...
FUKUOKA, Japan The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens enhanced antiviral...
View Article